AKZA — Akzo Nobel NV Income Statement
0.000.00%
Last trade - 00:00
- €10.73bn
- €15.00bn
- €10.67bn
- 82
- 47
- 70
- 77
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,276 | 8,530 | 9,587 | 10,846 | 10,668 |
Cost of Revenue | |||||
Gross Profit | 3,967 | 3,785 | 3,904 | 3,923 | 4,234 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,435 | 7,567 | 8,469 | 10,138 | 9,685 |
Operating Profit | 841 | 963 | 1,118 | 708 | 983 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 785 | 919 | 1,105 | 602 | 784 |
Provision for Income Taxes | |||||
Net Income After Taxes | 555 | 678 | 859 | 388 | 488 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 539 | 630 | 829 | 352 | 442 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 539 | 630 | 829 | 352 | 442 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.91 | 3.88 | 4.34 | 2.38 | 2.95 |
Dividends per Share | |||||
Special Dividends per Share |